The FDA’s strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the fall.

Dice is a biopharmaceutical company that uses a proprietary technology platform to develop new oral therapeutic drugs for autoimmune diseases.

The lawsuits are the opening salvo in a historic and potentially decisive battle over Medicare’s efforts to bring rising drug prices under control.